Polar Capital’s Tectonic Therapeutic TECX Stock Holding History

Polar Capital’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,366	Closed	-$4.26M	–	322
2020 Q2	$4.26M	Buy	+20,366	New	+$4.2M	0.04%	206

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Polar Capital's TECX Position: Q3 2020 in Review

Polar Capital sold out of Tectonic Therapeutic (TECX) in Q3 2020, closing a stake of 20,366 shares — an estimated $4.26M sold.

Polar Capital first reported a position in TECX in Q2 2020 and held it in 1 quarter. The position peaked at $4.26M in Q2 2020. 101 funds tracked by Wall St. Rank hold TECX as of Q3 2020.

Polar Capital reported no remaining Tectonic Therapeutic position as of Q3 2020 after selling out during the quarter.
Polar Capital sold 20,366 Tectonic Therapeutic shares in Q3 2020, an estimated $4.26M.
Polar Capital first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 1 quarter.
Polar Capital's Tectonic Therapeutic position peaked at $4.26M in Q2 2020.
101 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.